A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults with Severe Hypertriglyceridemia Protocol Number: AROAPOC3-2001
|Effective start/end date||3/1/21 → 3/31/25|
- ARROWHEAD PHARMACEUTICALS, INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.